Each Molecular Promise Accuracy
Follow Us We’ll share the latest news & our Successful cases for your reference. we are providing the best product & service for customers worldwide…
Invitation letter | Medlab Middle East- 2023
Invitation letter | Medlab Middle East 2023 Medlab 2023 will be held at Dubai World…
Hzymes help’s to get first mRNA vaccine IND approved by the US FDA
Hzymes help’s to get first mRNA vaccine IND approved by the US FDA Congratulations to Zhejiang…
Hzymes New Building officially inaugurated.
Hzymes New Building officially inaugurated. January 1, 2022 October 17 is a milestone time for every Hzymes person to celebrate…
Recent Posts:
Hzymes Biotech mRNA raw materials help domestic new COVID vaccines complete the US FDA IND application.
June 22, 2022, Zhejiang Haichang Biomedicine Technology Co., Ltd. (Haichang Biotech) independently developed a novel Coronavirus mRNA vaccine booster, a strategic cooperative project of the Cell and Gene Therapy Innovation Center (CGTIC)
Hzymes (Fujian)Biotechnology Co., Ltd. officially inaugurated
On June 23, 2022, the inauguration ceremony of Hzymes (Fujian) Biotechnology Co., Ltd. was held in the National University Science and Technology Park of Fuzhou University…
Hzymes invitation: BioCon China
Join us for the BioCon China Expo 2022 : The 9th International Biopharmaceutical Conference and Exhibition From July 20, 2022 to July 22, 2022, will be held in Hangzhou International Expo Center.
Hzymes booth No.：B37
TIDES USA 2022 | Hzymes Product Profile： recombinant Trypsin & Trypsin Assay Kit (ELISA)
The 2022 Biopharmaceutical Conference Tides USA will be launched soon. Hzymes will bring bio-fermentation products and quality control solutions such as recombinant trypsin and trypsin residue detection kits, to Boston to better help accelerate the R&D and production of biopharmaceuticals.
Hzymes invitation: TIDES USA
TIDES USA is the flagship must-attend event in the TIDES: Oligonucleotide & Peptide Therapeutics portfolio. It is the world’s largest gathering for those interested in accelerating oligonucleotide, peptide, mRNA and genome editing products from early discovery to late-stage development and commercialization.
OMICRON VARIANT SPREADING GLOBALLY, HZYMES COMMITS SAFETY SUPPLY OF CORE RAW MATERIALS OF DNA/RNA EXTRACTION KIT
Omicron variant accelerating its spread globally, lots of facilities and cities are under large-scale lockdown, and the domestic and international logistic and production are greatly influenced. Hzymes sets up management, R&D, production and service centers in Shanghai, Wuhan, Suzhou, Qingdao, Yichang etc. cities.